ADRA2A
MOLECULAR TARGETadrenoceptor alpha 2A
ADRA2A (adrenoceptor alpha 2A) is targeted by 84 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting ADRA2A
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
Showing top 50 of 84 compounds. Use the BiohacksAI search to explore all ADRA2A modulators.
About ADRA2A as a Drug Target
ADRA2A (adrenoceptor alpha 2A) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 84 compounds with documented ADRA2A interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
ADRA2A inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.